SCHEMBL14659554

SCHEMBL14659554

C[Si](C)(C)CCOC(=O)c1cccc(S(=O)(=O)Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
CA1 P00915 6/20 0.42
CA2 P00918 6/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 1/20 0.40
MEN1 O00255 1/20 0.39
AGTR1 P30556 1/20 0.39
KMT2A Q03164 1/20 0.39
LOX P28300 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10410092 0.83 TDP1 (0.53) TDP1CA1CA2LMNA
SCHEMBL24330535 0.82 TDP1 (0.53) TDP1LMNATSHRMAPK1RAB9A
SCHEMBL16784390 0.81 TDP1 (0.39) TDP1CA1CA2KDM4EALDH1A1
SCHEMBL397968 0.81 CYP4F2 (0.51) CA1CA2KDM4EALDH1A1LMNA
SCHEMBL7455946 0.80 LMNA (0.53) TDP1ALDH1A1LMNATSHRRAB9A
SCHEMBL7457332 0.80 LMNA (0.53) TDP1ALDH1A1LMNATSHRRAB9A
SCHEMBL14659582 0.79 ALDH1A1 (0.60) TDP1CA1CA2KDM4EALDH1A1
SCHEMBL10674511 0.79 TDP1 (0.45) TDP1CA1CA2ALDH1A1LMNA
SCHEMBL12176926 0.78 HSPD1 (0.55) TDP1CA1CA2ALDH1A1TSHR
SCHEMBL14666797 0.78 LMNA (0.62) KDM4ELMNARAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284295-B2 Tetrahydrobenzothiophene compound ASTELLAS PHARMA INC. (JP) 2016-03-15 US disclosed
US-9284295-B2 Tetrahydrobenzothiophene compound ASTELLAS PHARMA INC. (JP) 2016-03-15 US disclosed
EP-2565190-B1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC (JP) 2015-06-03 EP disclosed
US-20140329802-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-11-06 US disclosed
US-20140329802-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-11-06 US disclosed
US-20140329802-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-11-06 US disclosed
US-8729068-B2 Tetrahydrobenzothiophene compound ASTELLAS PHARMA INC. (JP) 2014-05-20 US disclosed
US-8729068-B2 Tetrahydrobenzothiophene compound ASTELLAS PHARMA INC. (JP) 2014-05-20 US disclosed
US-8729068-B2 Tetrahydrobenzothiophene compound ASTELLAS PHARMA INC. (JP) 2014-05-20 US disclosed
EP-2565190-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND Astellas Pharma Inc. (JP) 2013-03-06 EP disclosed
US-20130053369-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed
US-20130053369-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed
US-20130029973-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-01-31 US disclosed
US-20130029973-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329802-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND SLC34A2, SLC34A1, SLC10A2 TDP1 2326/4885CA1 2988/4885CA2 350/4885
US-20130029973-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND SLC34A2, SLC10A2, SLC34A1 TDP1 1886/4885CA1 2065/4885CA2 272/4885
US-20130053369-A1 TETRAHYDROBENZOTHIOPHENE COMPOUND SLC34A2, SLC34A1, SLC10A2 TDP1 2326/4885CA1 2988/4885CA2 350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.